Exercise for counteracting post-acute COVID-19 syndrome in patients with cancer: an old but gold strategy?

References

• WHO. Coronavirus Data. (Ed.). 2021. Available from: https://covid19.who.int/
   Google Scholar
• Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615.
   PubMed Web of Science ®Google Scholar
• Garassino MC, Whisenant JG, Huang LC, TERAVOLT Investigators, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21(7):914–922.
   PubMed Web of Science ®Google Scholar
• Zhang H, Han H, He T, et al. Clinical characteristics and outcomes of COVID-19-infected cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2021;113(4):371–380.
   PubMedGoogle Scholar
• Moreno-Pérez O, Merino E, Leon-Ramirez JM, COVID19-ALC Research Group, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378–383.
   PubMed Web of Science ®Google Scholar
• Cortellini A, Roldán E, Carmona Garcia MC, et al. Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection. Ann Oncol. 2021;32:S1130.
   Web of Science ®Google Scholar
• Patel AV, Friedenreich CM, Moore SC, et al. American college of sports medicine roundtable report on physical activity, sedentary behavior, and cancer prevention and control. Med Sci Sports Exerc. 2019;51(11):2391–2402.
   PubMed Web of Science ®Google Scholar
• Avancini A, Sartori G, Gkountakos A, et al. Physical activity and exercise in lung cancer care: will promises be fulfilled? Oncologist. 2020;25(3):e555–e569.
   PubMed Web of Science ®Google Scholar
• Scott JM, Zabor EC, Schwitzer E, et al. Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis. J Clin Oncol. 2018;36(22):2297–2305.
   PubMed Web of Science ®Google Scholar
• Padilha CS, Marinello PC, Galvão DA, et al. Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis. J Cancer Surviv. 2017;11(3):339–349.
   PubMed Web of Science ®Google Scholar
• Koeppel M, Mathis K, Schmitz KH, et al. Muscle hypertrophy in cancer patients and survivors via strength training. A meta-analysis and meta-regression. Crit Rev Oncol Hematol. 2021;163:103371.
   PubMed Web of Science ®Google Scholar
• Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–2390.
   PubMed Web of Science ®Google Scholar
• Kruijsen-Jaarsma M, Révész D, Bierings MB, et al. Effects of exercise on immune function in patients with cancer: a systematic review. Exerc Immunol Rev. 2013;19:120–143.
   PubMed Web of Science ®Google Scholar
• Woods JA, Davis JM, Smith JA, et al. Exercise and cellular innate immune function. Med Sci Sports Exerc. 1999;31(1):57–66.
   PubMed Web of Science ®Google Scholar
• Meneses-Echávez JF, Correa-Bautista JE, González-Jiménez E, et al. The effect of exercise training on mediators of inflammation in breast cancer survivors: a systematic review with meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1009–1017.
   PubMed Web of Science ®Google Scholar
• Fairey AS, Courneya KS, Field CJ, et al. Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial. Brain Behav Immun. 2005;19(5):381–388.
   PubMed Web of Science ®Google Scholar
• Laboratories ACoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
   PubMed Web of Science ®Google Scholar
• Innes E. Handgrip strength testing: a review of the literature. Aust Occup Ther J. 1999;46(3):120–140.
   Google Scholar
• Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser. 1995;854:1–452.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
   PubMed Web of Science ®Google Scholar
• Amireault S, Godin G, Lacombe J, et al. The use of the Godin-Shephard Leisure-Time physical activity questionnaire in oncology research: a systematic review. BMC Med Res Methodol. 2015;15:60.
   PubMed Web of Science ®Google Scholar
• McCrary JM, Goldstein D, Wyld D, et al. Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test. J Cancer Surviv. 2019;13(4):495–502.
   PubMed Web of Science ®Google Scholar
• van Sloten TT, Savelberg HH, Duimel-Peeters IG, et al. Peripheral neuropathy, decreased muscle strength and obesity are strongly associated with walking in persons with type 2 diabetes without manifest mobility limitations. Diabetes Res Clin Pract. 2011;91(1):32–39.
   PubMed Web of Science ®Google Scholar